KC-3349

EL4-TROP2-Middle-Cell-Line

×
34338
Home » Cell Lines » EL4-TROP2-Middle-Cell-Line

Background of EL4-TROP2-Middle-Cell-Line

TACSTD2 encodes trophoblast cell-surface antigen 2 (Trop2), a type I transmembrane glycoprotein involved in epithelial cell signaling, adhesion and proliferation. Trop2 is frequently expressed in solid tumors and is widely studied as a tumor-associated surface antigen and therapeutic target.

Specifications

Catalog NumberKC-3349
Cell Line NameEL4-TROP2-Middle-Cell-Line
NCBI/UniProt Accession NumberNM_002353.3
Clone Number1#
Host Cell LineEL4
DescriptionStable EL4 cell line expressing exogenous human Trop2 at a medium level
QuantityOne vial of frozen cells (≥2×106 cells)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% 1640+20% FBS+10% DMSO
Propagation Medium1640+10%FBS+10μg/mL Puromycin
Selection MarkerPuromycin
MorphologyLymphoblast-like
SubcultureSplit at a ratio of 1:4–1:8 every 2–3 days
Incubation37°C with 5% CO₂
StorageLiquid nitrogen immediately upon receiving
Doubling TimeEstimated 16–36 hours
Mycoplasma StatusNegative
In Vivo ValidationNA

Cell Line Generation

The EL4-Trop2-Medium cell line was generated using a lentiviral vector expressing the human Trop2 sequence, followed by selection for medium-expression clones.

Characterization

Figure 1: Characterization of human TROP2 overexpression in the EL4-Trop2-Medium stable clone using FACS.

Cell Resuscitation

  1. Pre-warm complete culture medium (1640 and 10% FBS) in a 37°C water bath.
  2. Rapidly thaw the cryovial in a 37°C water bath for 1–2 minutes with gentle agitation.
  3. Transfer the vial to a biosafety cabinet and disinfect the exterior with 70% ethanol.
  4. Aseptically transfer the cell suspension dropwise into a sterile centrifuge tube containing 9.0 mL of pre-warmed complete medium.
  5. Centrifuge at approximately 125×g for 5–7 minutes at room temperature; carefully aspirate the supernatant without disturbing the cell pellet.
  6. Gently resuspend the pellet in an appropriate volume of complete medium and transfer the suspension into a T25 flask.
  7. Incubate the flask at 37°C in a humidified 5% CO₂ incubator.
  8. Assess cell viability and morphology after 24 hours. If cells appear healthy, replace the medium with fresh medium supplemented with 10 μg/mL puromycin.
  9. Maintain the cells as a suspension culture and subculture according to cell density.

Cell Freezing

  1. Prepare the freezing medium (70% 1640, 20% FBS and 10% DMSO) freshly before use.
  2. Pre-chill the freezing medium on ice and label the cryovials accordingly.
  3. Transfer the cell suspension to a sterile conical tube and perform a cell count to determine total viability and density.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature; carefully aspirate the supernatant.
  5. Gently resuspend the cell pellet in chilled freezing medium, ensuring a minimum cell density of 3×10⁶ cells/mL.
  6. Aliquot 1 mL of the cell suspension into each pre-labeled cryovial.
  7. Place the cryovials into a CoolCell® container and store at -80°C overnight for controlled-rate cooling.
  8. Transfer the cryovials to liquid nitrogen for long-term storage the following day.

References

  1. Shen M, Liu S, Stoyanova T. The role of Trop2 in prostate cancer: an oncogene, biomarker, and therapeutic target. American Journal of Clinical and Experimental Urology. 2021;9(1):73–87.
  2. Wen Y, Ouyang D, Zou Q, et al. A literature review of the promising future of TROP2: a potential drug therapy target. Annals of Translational Medicine. 2022;10(24):1403.
  3. Sakach E, Sacks R, Kalinsky K. Trop-2 as a Therapeutic Target in Breast Cancer. Cancers. 2022;14(23):5936.

Use License Agreement

Research Use Only.
Not for use in diagnostic procedures or therapeutic applications.
Redistribution of the cell line or its derivatives is prohibited without prior written permission from Kyinno Biotechnology.